Results 201 to 210 of about 2,974,682 (398)

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody, Louise Murphy, Ruth Ryan, Rosemary Lyons, Wenyi Tang, Lorna Bourke   +5 more
wiley   +1 more source

Phosphodiesterase Inhibitor [PDF]

, 2020
openaire   +1 more source

Research Progress of Psychological Intervention Combined with Phosphodiesterase-5 Inhibitors in the Treatment of Male Erectile Dysfunction

Zhai Jiawen, Shiyu Li, Chuntao Wang, Huaichun Zhou   +3 more
openalex   +2 more sources

Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases [PDF]

Abudurousuli Adili, Aerken Dilihumaer, Huhu Zhu, Huifang Tang   +3 more
openalex   +1 more source

Upregulation of sphingomyelin and ABCA8 in response to TDP‐43 pathology in amyotrophic lateral sclerosis brain

Brain Pathology, EarlyView.
Increases in sphingomyelin in response to TDP‐43 pathology in the disease‐affected motor cortex of amyotrophic lateral sclerosis (ALS) brain. Abstract Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease characterized by the degeneration of motor neurons and the presence of TAR DNA‐binding protein 43 (TDP‐43 ...
Finula I. Isik, Russell Pickford, Nicolas Dzamko, Kerry‐Anne Rye, Woojin Scott Kim   +4 more
wiley   +1 more source

Phosphodiesterase inhibitor ameliorates senescent changes of renal interstitial pericytes in aging kidney. [PDF]

Aging Cell
Kim HD, Kim EN, Lim JH, Kim Y, Ban TH, Lee H, Kim YS, Park CW, Choi BS.   +8 more
europepmc   +1 more source

Tilapia Hepcidin 2-3 Peptide Modulates Lipopolysaccharide-induced Cytokines and Inhibits Tumor Necrosis Factor-α through Cyclooxygenase-2 and Phosphodiesterase 4D [PDF]

, 2010
Venugopal Rajanbabu, Chieh‐Yu Pan, Shang-Chun Lee, Wei-Ju Lin, Ching-Chun Lin, Chung‐Leung Li, Jyh‐Yih Chen   +6 more
openalex   +1 more source

A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults.

Archives of Dermatology, 2012
A. Samrao, T. M. Berry, Renato Goreshi, E. Simpson   +3 more
semanticscholar   +1 more source

Compartmentalisation in cAMP signalling: A phase separation perspective

British Journal of Pharmacology, EarlyView.
Cells rely on precise spatiotemporal control of signalling pathways to ensure functional specificity. The compartmentalisation of cyclic AMP (cAMP) and protein kinase A (PKA) signalling enables distinct cellular responses within a crowded cytoplasmic space.
Milda Folkmanaite, Manuela Zaccolo
wiley   +1 more source

Dual-Acting Nitric Oxide Donor and Phosphodiesterase Inhibitor TOP-N53 Increases Lifespan and Health Span of Caenorhabditis elegans. [PDF]

MicroPubl Biol
Rudgalvyte M, Atzei P, de Brito Francisco R, Naef R, Glauser DA.   +4 more
europepmc   +1 more source